Last €140.39 EUR
Change Today -1.28 / -0.90%
Volume 2.8K
As of 1:01 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger M. Perlmutter M.D., Ph.D.

Former Consultant, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 40 board members in 2 different organizations across 8 different industries.

See Board Relationships


Dr. Roger M. Perlmutter, M.D., Ph.D. has been Executive Vice President and President of Merck Research Laboratories at Merck & Co. Inc. since April 15, 2013. Dr. Perlmutter serves as Science Partner at The Column Group LLC. Dr. Perlmutter was a Professor in the Departments of Immunology, Biochemistry and Medicine at the University of Washington in Seattle from January 1991 to January 1997. From 1981 to 1984, he was a Lecturer in the Division of Biology at the California ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

Former Director and Member of Corporate Governance & Nominating Committee
Former Director
Non-Executive Director
Former Director and Member of Scientific Advisory Board


PhD 1979
Washington University, St. Louis
MD 1979
Washington University, St. Louis
Unknown/Other Education 1973
Reed College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,211,538

Stock Options*

Restricted Stock Awards$2,699,987
All Other Compensation$16,459
Unexercisable Options225,443
Unexercisable Options Value$1,142,996
Total Value of Options$1,142,996
Total Number of Options225,443

Total Compensation*

Total Annual Cash Compensation$1,851,697
Total Short Term Compensation$1,211,538
Other Long Term Compensation$2,716,446
Total Calculated Compensation$5,986,124
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMG:GR €140.39 EUR -1.28


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at